Crewe Advisors’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-27
Closed -$5.2K – 943
2023
Q2
$5.2K Buy
27
+1
+4% +$199 ﹤0.01% 457
2023
Q1
$5.26K Buy
26
+15
+136% +$2.41K ﹤0.01% 628
2022
Q4
$1.41K Sell
11
-54
-83% -$6.97K ﹤0.01% 889
2022
Q3
$9K Buy
65
+13
+25% +$2.12K ﹤0.01% 706
2022
Q2
$9K Buy
+52
New +$7.49K ﹤0.01% 642

Other funds holding SGEN

Crewe Advisors's SGEN Position: Q3 2023 in Review

Crewe Advisors sold out of Seagen Inc. Common Stock (SGEN) in Q3 2023, closing a stake of 27 shares — an estimated $5.2K sold.

Crewe Advisors first reported a position in SGEN in Q2 2022 and held it in 5 quarters. The position peaked at $9K in Q3 2022. 616 funds tracked by Wall St. Rank hold SGEN as of Q3 2023.

  • Crewe Advisors reported no remaining Seagen Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Crewe Advisors sold 27 Seagen Inc. Common Stock shares in Q3 2023, an estimated $5.2K.
  • Crewe Advisors first reported a position in Seagen Inc. Common Stock in Q2 2022 and held it in 5 quarters.
  • Crewe Advisors's Seagen Inc. Common Stock position peaked at $9K in Q3 2022.
  • 616 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q3 2023.

Based on Crewe Advisors's 13F filing for Q3 2023, filed 9 Nov 2023.